Skip navigation
logo
(AFX UK Focus) 2009-04-02 18:10
BRIEF-Lannett gives update on marketing Digoxin tablets
Article layout: raw

April 2 (Reuters) - Lannett Co Inc:

  • PROVIDES UPDATE ON MARKETING DIGOXIN TABLETS

  • SAYS HAS SECURED ADDITIONAL ACTIVE PHARMACEUTICAL INGREDIENT FOR DIGOXIN
    tablets, 0.125 mg and 0.25 mg

    ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here)

    COPYRIGHT

    Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

  • Re-organisations, re-structurings, name changes, AGM, EGM
    Article layout: raw
    Jump back to site navigation